Genetic polymorphisms in CYP2B6 may be associated with lung cancer risk in the Chinese Han population

References

• Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217–222. doi: 10.2991/jegh.k.191008.001
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. Ca A Cancer J Clinicians. 2015;65(2):87–108. doi: 10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet (London, England). 2017;389(10066):299–311. doi: 10.1016/S0140-6736(16)30958-8
   PubMed Web of Science ®Google Scholar
• Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the global burden of disease study 2016. Occup Environ Med. 2020;77(3):151–159. doi: 10.1136/oemed-2019-106012
   PubMed Web of Science ®Google Scholar
• Yu D, Zheng W, Johansson M, et al. Overall and central obesity and risk of lung cancer: a pooled analysis. JNCI. 2018;110(8):831–842. doi: 10.1093/jnci/djx286
   PubMedGoogle Scholar
• Morel H, Raynard B, d’Arlhac M, et al. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer. Lung Cancer. 2018;126:55–63. doi: 10.1016/j.lungcan.2018.07.005
   PubMed Web of Science ®Google Scholar
• O’Keeffe LM, Taylor G, Huxley RR, et al. Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis. BMJ Open. 2018;8(10):e021611. doi: 10.1136/bmjopen-2018-021611
   PubMed Web of Science ®Google Scholar
• Zhao M, Ma J, Li M, et al. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021;22(23):12808. doi: 10.3390/ijms222312808
   PubMed Web of Science ®Google Scholar
• Hardwick JP. Cytochrome P450 function and pharmacological roles in inflammation and cancer. Preface. Adv pharmacol (San Diego. Calif). 2015;74:xv–xxxi.
   Google Scholar
• Deenen MJ, Cats A, Beijnen JH, et al. Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism. Oncology. 2011;16(6):820–834. doi: 10.1634/theoncologist.2010-0259
   Google Scholar
• Liu H, Li G, Sturgis EM, et al. Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck. Int J Cancer. 2022;151(4):553–564. doi: 10.1002/ijc.34023
   PubMed Web of Science ®Google Scholar
• Thum T, Borlak J. Gene expression in distinct regions of the heart. Lancet (London, England). 2000;355(9208):979–983. doi: 10.1016/S0140-6736(00)99016-0
   PubMed Web of Science ®Google Scholar
• Wassenaar CA, Dong Q, Amos CI, et al. Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. Int J Mol Sci. 2013;14(4):8381–8392. doi: 10.3390/ijms14048381
   PubMed Web of Science ®Google Scholar
• de Araujo TK, Secolin R, Félix TM, et al. A multicentric association study between 39 genes and nonsyndromic cleft lip and palate in a Brazilian population. J Craniomaxillofac Surg. 2016;44(1):16–20. doi: 10.1016/j.jcms.2015.07.026
   PubMed Web of Science ®Google Scholar
• Gola D, Mahachie John JM, van Steen K, et al. A roadmap to multifactor dimensionality reduction methods. Brief Bioinform. 2016;17(2):293–308. doi: 10.1093/bib/bbv038
   PubMed Web of Science ®Google Scholar
• Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69(1):138–147. doi: 10.1086/321276
   PubMed Web of Science ®Google Scholar
• Motsinger AA, Ritchie MD. Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies. Hum Genomics. 2006;2(5):318–328. doi: 10.1186/1479-7364-2-5-318
   PubMedGoogle Scholar
• Uciechowski P, Imhoff H, Lange C, et al. Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression. J Leukoc Biol. 2011;90(2):377–388. doi: 10.1189/jlb.0409233
   PubMed Web of Science ®Google Scholar
• Huang D, Zhou Y, Yi X, et al. VannoPortal: multiscale functional annotation of human genetic variants for interrogating molecular mechanism of traits and diseases. Nucleic Acids Res. 2022;50(D1):D1408–d1416. doi: 10.1093/nar/gkab853
   PubMed Web of Science ®Google Scholar
• Qiu A, Xu H, Mao L, et al. A novel apaQTL-SNP for the modification of non-small-cell lung cancer susceptibility across histological subtypes. Cancers (Basel). 2022;14(21):5309. doi: 10.3390/cancers14215309
   PubMed Web of Science ®Google Scholar
• Huang Y, Bao T, Zhang T, et al. Machine learning study of SNPs in noncoding regions to predict non-small cell lung cancer susceptibility. Clin Oncol (R Coll Radiol). 2023;35(11):701–712. doi: 10.1016/j.clon.2023.08.010
   PubMed Web of Science ®Google Scholar
• Hurkmans EGE, Klumpers MJ, Vermeulen SH, et al. Analysis of drug metabolizing gene panel in osteosarcoma patients identifies association between variants in SULT1E1, CYP2B6 and CYP4F8 and methotrexate levels and toxicities. Front Pharmacol. 2020;11:1241. doi: 10.3389/fphar.2020.01241
   PubMed Web of Science ®Google Scholar
• Li J, Sun Z, Cui Y, et al. Knockdown of LMNB1 inhibits the proliferation of lung adenocarcinoma cells by inducing DNA damage and cell senescence. Front Oncol. 2022;12:913740. doi: 10.3389/fonc.2022.913740
   PubMed Web of Science ®Google Scholar
• Wang JF, Xi ZN, Su HJ, et al. SP1-induced overexpression of LINC00520 facilitates non-small cell lung cancer progression through miR-577/CCNE2 pathway and predicts poor prognosis. Hum Cell. 2021;34(3):952–964. doi: 10.1007/s13577-021-00518-y
   PubMed Web of Science ®Google Scholar
• Guo G, Li L, Song G, et al. miR‑7/SP1/TP53BP1 axis may play a pivotal role in NSCLC radiosensitivity. Oncol Rep. 2020;44(6):2678–2690. doi: 10.3892/or.2020.7824
   PubMed Web of Science ®Google Scholar
• Zheng X, Sarode P, Weigert A, et al. The HDAC2-SP1 axis orchestrates protumor macrophage polarization. Cancer Res. 2023;83(14):2345–2357. doi: 10.1158/0008-5472.CAN-22-1270
   PubMed Web of Science ®Google Scholar
• Xing YL, Liu F, Li JF, et al. Case-control study on impact of the telomerase reverse transcriptase gene polymorphism and additional single nucleotide polymorphism (SNP)- SNP interaction on non-small cell lung cancers risk in Chinese han population. J Clin Lab Analysis. 2016;30(6):1071–1077. doi: 10.1002/jcla.21982
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang C, Cheng Y, et al. IL1RL1 polymorphisms rs12479210 and rs1420101 are associated with increased lung cancer risk in the Chinese Han population. Front Genet. 2023;14:1183528. doi: 10.3389/fgene.2023.1183528
   PubMed Web of Science ®Google Scholar